| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/06/2013 | CN102958914A 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators |
| 03/06/2013 | CN102952124A 3,4-bis(1-hydro-5-tetrazolyl)furoxan ionic salt containing energy and preparation method thereof |
| 03/06/2013 | CN102952123A Iloperidone impurity and its preparation method |
| 03/06/2013 | CN102952120A Compound for electroluminescent device and organic electroluminescent devices using the same |
| 03/06/2013 | CN101965344B Isoxazole-imidazole derivatives |
| 03/06/2013 | CN101743232B Compounds and methods for modulating fxr |
| 03/06/2013 | CN101679359B Quinolines and their therapeutic use |
| 03/06/2013 | CN101223157B Methods for synthesizing heterocyclic compounds |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389720 Quinolone neuropeptide S receptor antagonists |
| 03/05/2013 | US8389717 Modulators for amyloid beta |
| 03/05/2013 | US8389698 Tanaproget derivatives, metabolites, and uses thereof |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389550 Isoxazoles / O-pyridines with ethyl and ethenyl linker |
| 03/05/2013 | US8389543 Metalloenzyme inhibitor compounds |
| 03/05/2013 | US8389541 Inhibitors of protein tyrosine kinase activity |
| 03/05/2013 | US8389520 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 03/05/2013 | US8389518 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/05/2013 | US8389511 Bicyclic heterocyclic derivative |
| 03/05/2013 | US8389508 Heterocyclic compounds |
| 03/05/2013 | US8389442 N-phenyl-′(4-pyridyl)-azinyl!amine derivatives as plant protection agents |
| 03/05/2013 | CA2708324C Viral polymerase inhibitors |
| 03/05/2013 | CA2569883C Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 02/28/2013 | WO2013027845A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/28/2013 | WO2013027225A1 Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl} morpholin-3-one |
| 02/28/2013 | WO2013027196A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 02/28/2013 | WO2013027188A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 02/28/2013 | WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors |
| 02/28/2013 | WO2013027001A1 Compounds and their use to treat histamine h3 related disorders |
| 02/28/2013 | WO2013026933A1 Isoxazoline derivatives as insecticidal compounds |
| 02/28/2013 | WO2013026931A1 Isoxazoline derivatives as insecticidal compounds |
| 02/28/2013 | WO2013026930A1 Process for the preparation of thietane derivatives |
| 02/28/2013 | WO2013026836A1 Fungicide hydroximoyl-tetrazole derivatives |
| 02/28/2013 | WO2013026695A1 Isoxazoline derivatives as insecticidal compounds |
| 02/28/2013 | WO2013026587A1 1,4 disubstituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders |
| 02/28/2013 | WO2013026163A1 Hepatitis c inhibitor compounds |
| 02/28/2013 | US20130053557 Processes for preparing linezolid |
| 02/28/2013 | US20130053436 Compounds, compositions and methods |
| 02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053405 Carrier linked paliperidone prodrugs |
| 02/28/2013 | US20130053396 Piperidine and piperazine derivatives as smo antagonists |
| 02/28/2013 | US20130053386 Diaryl ether derivatives as notch sparing gamma secretase inhibitors |
| 02/28/2013 | US20130053385 Method of combating and controlling pests |
| 02/28/2013 | US20130053384 Certain Chemical Entities, Compositions, and Methods |
| 02/28/2013 | US20130053383 Indazoles |
| 02/28/2013 | US20130053381 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053378 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
| 02/28/2013 | US20130053376 Novel tyrosine kinase inhibitors |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/28/2013 | US20130053372 5-ht receptor modulators |
| 02/28/2013 | US20130053369 Tetrahydrobenzothiophene compound |
| 02/28/2013 | US20130053362 Heterocyclic compounds and uses thereof |
| 02/28/2013 | US20130053359 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053343 Compounds and methods for inhibiting serotonin synthesis |
| 02/28/2013 | US20130053341 Therapeutic compounds and related methods of use |
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 02/28/2013 | US20130053301 Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| 02/28/2013 | US20130052138 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 02/28/2013 | US20130048956 Compound for electroluminescent device and organic electroluminescent devices using the same |
| 02/28/2013 | CA2846507A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 02/28/2013 | CA2846122A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/28/2013 | CA2845578A1 Pyrimidine pde10 inhibitors |
| 02/28/2013 | CA2845093A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 02/27/2013 | EP2562174A1 Herbicidal 6-Oxo-1,6-dihydropyrimidin-5-carboxamides and 2-Oxo-1,2-dihydropyridin-3-carboxamides |
| 02/27/2013 | EP2560969A1 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists |
| 02/27/2013 | EP2560967A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors |
| 02/27/2013 | EP2560653A1 Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 02/27/2013 | EP2560488A1 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| 02/27/2013 | CN102947299A Alkaloid aminoester derivatives and medicinal composition thereof |
| 02/27/2013 | CN102947296A 5-aryl isoxazolines for controlling pests |
| 02/27/2013 | CN102947292A Nitrogen containing heteroaryl compounds |
| 02/27/2013 | CN102947289A Arylethynyl derivatives |
| 02/27/2013 | CN102947281A Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 02/27/2013 | CN102947279A Process for producing imine compounds for combating invertebrate pests |
| 02/27/2013 | CN102947272A 2 -aminopyridine derivatives useful as inhibitors of atr kinase |
| 02/27/2013 | CN102942564A Asymmetric bismaleimide containing 1, 3, 4-oxadiazole structure and preparation method thereof |
| 02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 02/27/2013 | CN101511800B Triazolyl phenyl benzenesulfonamides |
| 02/26/2013 | US8383830 Cyanine compounds and their use in staining biological samples |
| 02/26/2013 | US8383822 Substituted oxazolidinones and their use |
| 02/26/2013 | US8383660 Dibenzyl amine compounds and derivatives |
| 02/26/2013 | US8383651 Compounds which selectively modulate the CB2 receptor |
| 02/26/2013 | US8383622 Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity |
| 02/26/2013 | US8383621 Acylpiperazinones and their use as pharmaceuticals |
| 02/26/2013 | US8383619 Pharmaceutical compounds |
| 02/26/2013 | US8383616 Aryl isoxazole compounds with antitumoural activities |
| 02/26/2013 | US8383615 Azetidine 2-carboxamide derivatives which modulate the CB2 receptor |
| 02/26/2013 | US8383094 Hepatitis C virus inhibitors |
| 02/26/2013 | CA2534682C Capped pyrazinoylguanidine sodium channel blockers |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | WO2013025560A1 Sweet flavor modifier |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024011A1 Indazole compounds, compositions and methods of use |
| 02/21/2013 | WO2012118715A9 Non-peptidic quenched fluorescent imaging probes |
| 02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
| 02/21/2013 | US20130045977 TGF-beta SIGNAL TRANSDUCTION INHIBITOR |
| 02/21/2013 | US20130045976 Isoindoline compounds and methods of their use |